Social Media

Using humor: Why pharma doesn't need to fear social media

Using humor: Why pharma doesn't need to fear social media

By

Healthcare and tech executives say it's possible for pharma to engage, use humor, and have fun on social media.

Sermo opens up platform to healthcare marketers

Sermo opens up platform to healthcare marketers

By

The Facebook for doctors launches Pages, allowing healthcare companies to establish a presence on Sermo and engage with physicians.

Twitter, Facebook, Google execs examine regulatory limits for drugmakers

Twitter, Facebook, Google execs examine regulatory limits for drugmakers

By

Technology executives discussed how pharma companies can leverage social media to better engage with patients online.

'Deadpool' Imparts a Lesson to Pharma Marketers

'Deadpool' Imparts a Lesson to Pharma Marketers

Social is a big deal in healthcare. Marketers can use it to create positive chatter and win greater awareness, recognition, and credibility among target audiences.

Marketers Rely on Email and Social Media, Rather than Face Time

Marketers Rely on Email and Social Media, Rather than Face Time

Curating personal relationships is one of the most valuable functions medical marketers can provide. The best way is through face-to-face interaction.

Pharma companies turn to LinkedIn to engage

Pharma companies turn to LinkedIn to engage

By

Part of LinkedIn's appeal lies in the high level of engagement of its members and the potential for precise targeting of content and talent searches.

Leadership Exchange: Social Listening

Leadership Exchange: Social Listening

By

Social listening can help all along the value chain—from research and discovery to developing marketing plans and strategy.

Why UCB isn't afraid of social media

Why UCB isn't afraid of social media

By

The company "embraces" adverse-event reporting and knows not to expect monetary ROI from unbranded initiatives, says its US-based social media lead.

Five things for pharma marketers to know: Wednesday, November 4, 2015

Five things for pharma marketers to know: Wednesday, November 4, 2015

By

Many patients allow doctors to access their social-media accounts; Turing will reportedly lower the price of Daraprim by 10%; WebMD reports boost in traffic

How To Fix The 'Problems' With Social Listening

How To Fix The 'Problems' With Social Listening

Work hard to get everyone in your company to understand what you can learn from social listening—you'll know you're successful when inquisitive minds throughout the company start asking you the question, "Can we find out what patients are saying about this brand online?"

Omitting risk info in ads is top reason for FDA warning

Omitting risk info in ads is top reason for FDA warning

By

An analysis conducted by J&J executives found that 58% of FDA warning letters and untitled letters over the last two years omitted risk information.

Bristol-Myers Squibb promotes employees

Bristol-Myers Squibb promotes employees

By

The drugmaker launched its first YouTube channel as it kicked off the campaign.

Pfizer's Susman: Customer-company relationship has changed

Pfizer's Susman: Customer-company relationship has changed

By

Stakeholder activists, social media and an increasingly global market are three defining issues for companies operating in the 21st century.

Is It Finally Time for Pharma to Change the Way It Uses Facebook?

Is It Finally Time for Pharma to Change the Way It Uses Facebook?

Pharma has hidden behind the ability to turn commenting off on Facebook pages, allowing marketers to use the channel much as they would a typical web page.

Five things for pharma marketers to know: Monday, August 31

Five things for pharma marketers to know: Monday, August 31

By

Kim Kardashian posts corrective information on Instagram and Twitter; DPP-4 inhibitors are linked to joint pain; doctors question off-label prescriptions of PCSK9 inhibitors

Is It Time to Change the Vaccine Dialogue? Campaigns Present Opportunities for Pharma

Is It Time to Change the Vaccine Dialogue? Campaigns Present Opportunities for Pharma

While social media can be a tool for pharma to help educate the public, it has also become a forum for the public to express their views about pharma, and it's not always flattering, as evidenced by the recent antivaccine movement.

Bad ad watchdog slams Kardashian's social-media post

Bad ad watchdog slams Kardashian's social-media post

By

The FDA said Kim Kardashian West's promotion of morning-sickness pill Diclegis misbranded the product by understating its risks.

Healthcare reimagined: Fortner finesses McKesson's bold vision

Healthcare reimagined: Fortner finesses McKesson's bold vision

From evolving healthcare laws to social engagement, litigation crises to media relations, McKesson's PR chief is hands-on in efforts to enhance the brand's image.

Patients expect pharma will boost engagement

Patients expect pharma will boost engagement

By

The pharma business needs to take engagement far more seriously than it has in the past. At the same time, there are signs that the industry is finally acting with more urgency and even transparency.

Treato bolsters social-media insight

The consumer-insights firm said it's debuting a listening feature that will make it harder for pharma to ignore Twitter, Reddit and the other big social platforms.

Doximity expands professional reach

Its alliance with the Society of Hospital Medicine will expand the network's reach among medical professionals.

Pfizer's "Get Old" campaign gets youthful

Pfizer's "Get Old" campaign gets youthful

By

The three-year-old campaign's youthful tone evolves as its audience ages.

New bill seeks to spur FDA to form clearer social media rules

New bill seeks to spur FDA to form clearer social media rules

By

Rep. Billy Long introduced legislation that is meant to push the FDA to implement clearer guidelines for regulating drug product information on social media.

UCLA looks to Twitter for health trends

UCLA looks to Twitter for health trends

By

Researchers say Twitter could provide critical insight into health needs for hard-to-reach groups.

Hints from the pros: Social media done well requires risk

Hints from the pros: Social media done well requires risk

By

Successful social-media engagement is not about the perfect picture or a tightly controlled brand. Instead, panelists at the Hub Convene conference indicated it's a matter of letting the audience take hold

University develops program to turn social media into adverse drug reaction data

A group of computer science and engineering students at the Carlos III Universidad in Madrid used natural language processing techniques to translate social-media and forum posts into adverse drug reaction data.

MM&M's top reads of 2014

MM&M's top reads of 2014

A look at the content that grabbed most reader interest over the past year.

Mixed reaction to a health-centric Facebook feature

Mixed reaction to a health-centric Facebook feature

The ACLU is among those questioning the positives of the rumored healthcare effort.

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

OPINION


Click here to learn about the Agency Issue. 

Email Newsletters